首页 > 市场调查报告书 > 製药

循环系统

到 2030 年北美心臟移植市场预测 - 区域分析 - 按手术类型、类型和最终用户

市场调查报告书

商品编码

1510694

到 2030 年北美心臟移植市场预测 - 区域分析 - 按手术类型、类型和最终用户

North America Heart Transplant Market Forecast to 2030 - Regional Analysis - by Surgery Type, Type, and End User

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 68 Pages | 订单完成后即时交付

价格

简介目录图表

北美心臟移植市场预计将从2022年的72.521亿美元成长到2030年的171.9272亿美元。

人工智慧在移植手术的应用推动了北美心臟移植市场

由人工智慧 (AI) 支援的独特设计系统有助于检测心臟移植后宿主排斥的早期迹象和严重程度。心内膜心肌活检（EMB）筛检代表了心臟移植后识别同种异体移植排斥反应的护理标准。 2022年，设计了一种新的人工智慧系统，称为心臟排斥评估神经估计器（CRANE），它可以与医疗评估结合使用，以实现快速、精确的诊断。 CRANE 也有助于减少宿主体内心臟排斥的存在和严重程度的差异。它是一个基于深度学习的人工智慧系统，用于自动评估从 EMB 获得的十亿像素全幻灯片影像。 2020 年，美国国立卫生研究院拨款 320 万美元用于探索人工智慧在心臟移植方面的能力的研究。借助这笔资助，来自佩雷尔曼医学院（宾州大学）、凯斯西储大学、克利夫兰诊所和雪松-西奈医疗中心的研究人员旨在研究导致新心臟排斥的原因以及如何处理它。他们使用人工智慧分析心臟活检组织影像，找到在新的心臟排斥反应中发挥重要作用的免疫细胞类型。因此，人工智慧在心臟移植手术中的采用可能会在未来几年为市场带来新的趋势。

北美心臟移植市场概况

北美的心臟移植市场分为美国、加拿大和墨西哥。 2022年，北美占据最大的市场份额，市场成长可归因于老年人口激增、心血管疾病盛行率以及心臟衰竭病例增加。慢性肾臟病发生率的增加和老年人口的增加是促进美国心臟移植市场成长的关键因素。根据美国心臟协会提供的资料，美国每年新增约 100 万心臟衰竭病例，预计到 2030 年将有超过 800 万人患有心臟衰竭。被诊断出患有早期心臟衰竭。

美国食品药物管理局 (FDA) 越来越多地批准各种心臟移植手术和产品。此外，大公司的存在也有利于该国的市场。 2022 年 4 月，TransMedics Group, Inc. 的 OCS Heart 获得 FDA 上市前批准。

北美心臟移植市场收入及 2030 年预测（百万美元）

北美心臟移植市场细分

北美心臟移植市场分为手术类型、类型、最终用户和国家。

根据手术类型，北美心臟移植市场分为原位心臟移植和异位心臟移植。 2022年，原位心臟移植细分市场在北美心臟移植市场中占据更大份额。

从类型来看，北美心臟移植市场分为供体活体心臟和人工心臟。 2022年，供体活体心臟细分市场在北美心臟移植市场中占据较大份额。

根据最终用户，北美心臟移植市场分为医院、心臟中心等。 2022年，医院细分市场在北美心臟移植市场中占据最大份额。

根据国家/地区，北美心臟移植市场分为美国、加拿大和墨西哥。 2022年，美国将主导北美心臟移植市场。

Terumo Corp、Evaheart Inc、Abbott Laboratories、SynCardia Systems LLC、BiVACOR Inc、BioVentrix Inc、Berlin Heart GmbH、LivaNova Plc、Jarvik Heart Inc 和 Calon Cardio-Technology Ltd 是北美心臟移植市场上的一些领先公司。

A uniquely designed system backed by artificial intelligence (AI) facilitates the detection of early signs and seriousness of the host rejection post-heart transplantation. The endomyocardial biopsy (EMB) screening signifies the standard of care for identifying allograft rejections after a heart transplant. In 2022, a new AI system was designed known as the Cardiac Rejection Assessment Neural Estimator (CRANE), which can be used in tandem with medical assessments for rapid and precise diagnosis. CRANE also helps reduce differences regarding the presence and severity of heart rejection in the host body. It is a deep learning-based AI system for the automated assessment of gigapixel whole-slide images obtained from EMBs. In 2020, the National Institute of Health granted US$ 3.2 million to studies based on the exploration of the capabilities of AI in heart transplants. With this grant, researchers from Perelman School of Medicine (the University of Pennsylvania), Case Western Reserve University, Cleveland Clinic, and Cedars-Sinai Medical Center aimed to study what causes the rejection of a new heart and how to manage it. They used AI to analyze cardiac biopsy tissue images, finding the types of immune cells that play an instrumental role in new heart rejection. Thus, the adoption of AI in heart transplantation procedures is likely to bring new trends in the market in the coming years.

North America Heart Transplant Market Overview

The heart transplant market in North America is segmented into the US, Canada, and Mexico. North America accounted for the largest market share in 2022, and the market growth can be attributed to an upsurge in the geriatric population, the prevalence of cardiovascular diseases, and an increase in heart failure cases. The increasing incidences of chronic kidney diseases and the rising geriatric population are the key factors contributing to the heart transplant market growth in the US. According to data provided by the American Heart Association Inc., ~1 million new heart failure cases are registered annually in the US, and more than 8 million people are estimated to suffer from heart failure by 2030. As per the Health Research Funding Organization, ~555,000 people were diagnosed with the beginning stages of heart failure in the US in 2021. Cardiovascular diseases (CVDs) generally lead to heart failure or terminal heart disease, which bolsters the demand for heart transplants.

The US Food and Drug Administration (FDA) is increasingly approving various heart transplant procedures and products. In addition, the presence of major companies benefits the market in this country. In April 2022, TransMedics Group, Inc. received premarket FDA approval for its OCS Heart.

North America Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)

North America Heart Transplant Market Segmentation

The North America heart transplant market is segmented into surgery type, type, end user, and country.

Based on surgery type, the North America heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the North America heart transplant market in 2022.

In terms of type, the North America heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the North America heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.

Based on end user, the North America heart transplant market is segmented into hospitals, cardiac centers, and others. The hospitals segment held the largest share of the North America heart transplant market in 2022.

Based on country, the North America heart transplant market is segmented into the US, Canada, and Mexico. The US dominated the North America heart transplant market in 2022.

Terumo Corp, Evaheart Inc, Abbott Laboratories, SynCardia Systems LLC, BiVACOR Inc, BioVentrix Inc, Berlin Heart GmbH, LivaNova Plc, Jarvik Heart Inc, and Calon Cardio-Technology Ltd are some of the leading companies operating in the North America heart transplant market.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Heart Transplant Market - Key Industry Dynamics

4.1 Heart Transplant Market - Key Industry Dynamics
4.2 Market Drivers
- 4.2.1 Increasing Target Disease Incidence
- 4.2.2 Growing Geriatric Population
4.3 Market Restraints
- 4.3.1 High Cost of Surgeries
4.4 Market Opportunities
- 4.4.1 Ongoing Research and Development
4.5 Future Trends
- 4.5.1 Use of AI in Transplantation Procedures
4.6 Impact of Drivers and Restraints:

5. Heart Transplant Market - North America Market Analysis

5.1 Heart Transplant Market Revenue (US$ Million), 2020 - 2030
5.2 Heart Transplant Market Forecast and Analysis

6. North America Heart Transplant Market Analysis - Surgery Type

6.1 Overview
6.2 Orthotopic Heart Transplant
- 6.2.1 Overview
- 6.2.2 Orthotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Heterotopic Heart Transplant
- 6.3.1 Overview
- 6.3.2 Heterotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)

7. North America Heart Transplant Market Analysis - Type

7.1 Overview
7.2 Donor Live Heart
- 7.2.1 Overview
- 7.2.2 Donor Live Heart Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Artificial Hearts
- 7.3.1 Overview
- 7.3.2 Artificial Hearts Market, Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Ventricular Assisted Device
    - 7.3.2.1.1 Ventricular Assisted Device Market, Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.2 Total Artificial Heart
    - 7.3.2.2.1 Total Artificial Heart Market, Revenue and Forecast to 2030 (US$ Million)

8. North America Heart Transplant Market Analysis - End User

8.1 Overview
8.2 Hospitals
- 8.2.1 Overview
- 8.2.2 Hospitals Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Cardiac Centers
- 8.3.1 Overview
- 8.3.2 Cardiac Centers Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. North America Heart Transplant Market - Country Analysis

9.1 North America
- 9.1.1 North American Transplant Market Overview
- 9.1.2 North America Heart Transplant Market Breakdown by Country (2022 and 2030)
  - 9.1.2.1 US: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.1.1 Overview
    - 9.1.2.1.2 United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 9.1.2.1.3 United States Heart Transplant Market Breakdown by Surgery Type
    - 9.1.2.1.4 United States Heart Transplant Market Breakdown by Type
    - 9.1.2.1.4.1 United States Heart Transplant Market Breakdown by Artificial Hearts
    - 9.1.2.1.5 United States Heart Transplant Market Breakdown by End User
  - 9.1.2.2 Canada: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.1 Overview
    - 9.1.2.2.2 Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 9.1.2.2.3 Canada Heart Transplant Market Breakdown by Surgery Type
    - 9.1.2.2.4 Canada Heart Transplant Market Breakdown by Type
    - 9.1.2.2.4.1 Canada Heart Transplant Market Breakdown by Artificial Hearts
    - 9.1.2.2.5 Canada Heart Transplant Market Breakdown by End User
  - 9.1.2.3 Mexico: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.3.1 Overview
    - 9.1.2.3.2 Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 9.1.2.3.3 Mexico Heart Transplant Market Breakdown by Surgery Type
    - 9.1.2.3.4 Mexico Heart Transplant Market Breakdown by Type
    - 9.1.2.3.4.1 Mexico Heart Transplant Market Breakdown by Artificial Hearts
    - 9.1.2.3.5 Mexico Heart Transplant Market Breakdown by End User

10. Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Heart Transplant Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Terumo Corp
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Evaheart Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott Laboratories
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 SynCardia Systems LLC
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 BiVACOR Inc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 BioVentrix Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Berlin Heart GmbH
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 LivaNova Plc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Jarvik Heart Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments

12. Appendix

12.1 About the Insight Partners

简介目录图表

List Of Tables

Table 1. Heart Transplant Market Segmentation
Table 2. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Table 3. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) - Surgery Type
Table 4. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) - Type
Table 5. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) - End User
Table 6. North America Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Country
Table 7. United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
Table 8. United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
Table 9. United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
Table 10. United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
Table 11. Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
Table 12. Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
Table 13. Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
Table 14. Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
Table 15. Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Surgery Type
Table 16. Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Type
Table 17. Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By Artificial Hearts
Table 18. Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
Table 19. Recent Inorganic Growth Strategies in the Heart Transplant Market
Table 20. Recent Organic Growth Strategies in the Heart Transplant Market

List Of Figures

Figure 1. Heart Transplant Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Heart Transplant Market Revenue (US$ Million), 2020 - 2030
Figure 4. Heart Transplant Market Share (%) - Surgery Type, 2022 and 2030
Figure 5. Orthotopic Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Heterotopic Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Heart Transplant Market Share (%) - Type, 2022 and 2030
Figure 8. Donor Live Heart Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Artificial Hearts Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Ventricular Assisted Device Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Total Artificial Heart Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Heart Transplant Market Share (%) - End User, 2022 and 2030
Figure 13. Hospitals Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Cardiac Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. North America: Heart Transplant Market, by Key Country - Revenue (2022) (US$ Million)
Figure 17. North America Heart Transplant Market Breakdown by Country (2022 and 2030)
Figure 18. United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 19. Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 20. Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 21. Growth Strategies in the Heart Transplant Market